Publications by authors named "D Ross Camidge"

Claim this Profile
M
Management of Central Nervous System Progression With Dose-Escalated Lorlatinib in ALK-Positive NSCLC: A Report of 2 Cases and Literature Review.
Noah H Richardson, Alexander S Watson, Tejas Patil, David Ross Camidge, Nasser H Hanna

Clin Lung Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics of Short-Term Survivors With or -Altered Metastatic NSCLC.
Kai-Lin Liu, Alex Watts, Connor B Grady, Geoffrey Liu, Devalben Patel, D Ross Camidge

JTO Clin Res Rep· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durable response with mutation-guided inhibition in a patient with metastatic epithelioid inflammatory myofibroblastic sarcoma: A case report.
Sumra S Chaudhry, D Ross Camidge, Michael R Clay, Breelyn A Wilky

Rare Tumors· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence, molecular characterization, and prognosis of c-Met protein overexpression in a real-world cohort of patients with non-squamous non-small cell lung cancer.
Jair Bar, Mona H Cai, Yookyung Christy Choi, Shobhit Baijal, Weilong Zhao, D Ross Camidge

Acta Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated molecular and clinical characterization of pulmonary large cell neuroendocrine carcinoma.
Amin H Nassar, Chul Kim, Tolulope Adeyelu, Elias Bou Farhat, Hassan Abushukair, D Ross Camidge

Nat Commun· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis